SCIACOVELLI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.313
AS - Asia 3.256
EU - Europa 2.610
AF - Africa 652
SA - Sud America 634
Continente sconosciuto - Info sul continente non disponibili 91
OC - Oceania 61
Totale 14.617
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.943
IT - Italia 1.253
SG - Singapore 1.068
CN - Cina 584
BR - Brasile 398
VN - Vietnam 349
HK - Hong Kong 288
PL - Polonia 174
FR - Francia 143
BD - Bangladesh 133
DE - Germania 105
FI - Finlandia 104
IN - India 100
SE - Svezia 100
RU - Federazione Russa 88
NL - Olanda 86
GB - Regno Unito 70
CA - Canada 65
JP - Giappone 56
AR - Argentina 55
ID - Indonesia 52
IQ - Iraq 48
UA - Ucraina 41
TR - Turchia 40
MX - Messico 38
EC - Ecuador 36
ES - Italia 36
ZA - Sudafrica 36
PH - Filippine 34
SA - Arabia Saudita 31
TN - Tunisia 31
EG - Egitto 29
PK - Pakistan 29
MU - Mauritius 28
MA - Marocco 26
UZ - Uzbekistan 26
ET - Etiopia 24
PT - Portogallo 24
VE - Venezuela 24
PS - Palestinian Territory 23
RO - Romania 23
AZ - Azerbaigian 22
CI - Costa d'Avorio 22
CO - Colombia 22
GR - Grecia 22
NI - Nicaragua 22
PE - Perù 22
AE - Emirati Arabi Uniti 21
AT - Austria 21
MY - Malesia 21
AO - Angola 20
GT - Guatemala 20
KR - Corea 20
LC - Santa Lucia 20
BA - Bosnia-Erzegovina 19
CG - Congo 19
CL - Cile 19
HU - Ungheria 19
LA - Repubblica Popolare Democratica del Laos 19
MN - Mongolia 19
NP - Nepal 19
TH - Thailandia 19
BF - Burkina Faso 18
CU - Cuba 18
DZ - Algeria 18
IE - Irlanda 18
KE - Kenya 18
LB - Libano 18
NO - Norvegia 18
PY - Paraguay 18
UG - Uganda 18
YE - Yemen 18
CH - Svizzera 17
DO - Repubblica Dominicana 17
GN - Guinea 17
KG - Kirghizistan 17
KZ - Kazakistan 17
MG - Madagascar 17
PA - Panama 17
TJ - Tagikistan 17
TZ - Tanzania 17
ZW - Zimbabwe 17
AL - Albania 16
GE - Georgia 16
LU - Lussemburgo 16
LY - Libia 16
ME - Montenegro 16
RW - Ruanda 16
UY - Uruguay 16
BJ - Benin 15
BS - Bahamas 15
BZ - Belize 15
CR - Costa Rica 15
IS - Islanda 15
KH - Cambogia 15
NC - Nuova Caledonia 15
SK - Slovacchia (Repubblica Slovacca) 15
TW - Taiwan 15
ZM - Zambia 15
AM - Armenia 14
Totale 13.894
Salva come PNG Salva come JPEG
Città #
Fairfield 796
Ashburn 715
San Jose 713
Singapore 669
Woodbridge 484
Houston 351
Ann Arbor 292
Cambridge 291
Seattle 271
Chandler 270
Hong Kong 260
Wilmington 248
Bytom 141
Council Bluffs 121
Milan 114
Santa Clara 113
Ho Chi Minh City 112
Beijing 109
Boardman 96
Princeton 92
Hanoi 89
Los Angeles 84
San Diego 82
Rome 67
Lauterbourg 65
Medford 65
Helsinki 58
New York 45
Padova 45
Jacksonville 43
Nanjing 43
Des Moines 42
Roxbury 41
Dallas 35
São Paulo 35
Florence 34
Trento 34
Atlanta 33
Chicago 31
Tokyo 31
Bologna 27
Tashkent 24
Baku 22
Naples 22
Buffalo 21
Managua 21
Abidjan 20
Castries 20
Frankfurt am Main 20
Jinan 20
London 20
Genoa 18
Haiphong 18
Munich 18
Vientiane 18
Conakry 17
Hebei 17
Kampala 17
Antananarivo 16
Guangzhou 16
Harare 16
Havana 16
Kigali 16
Montevideo 16
Montreal 16
Nairobi 16
Panama City 16
San Francisco 16
Shenyang 16
Ulan Bator 16
Baghdad 15
Brasília 15
Da Nang 15
Dar es Salaam 15
Johannesburg 15
Nanchang 15
Noumea 15
Dong Ket 14
Dublin 14
Luanda 14
Lusaka 14
Nassau 14
Orem 14
Ouagadougou 14
San José 14
Warsaw 14
Amman 13
Bishkek 13
Cotonou 13
Dakar 13
Dushanbe 13
Guatemala City 13
Luxembourg 13
Phnom Penh 13
Rio de Janeiro 13
Shanghai 13
Trieste 13
Addis Ababa 12
Kingstown 12
Niamey 12
Totale 8.222
Salva come PNG Salva come JPEG
Nome #
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 688
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 648
Protocollo operativo per la verifica della comparabilità dei risultati di laboratorio ottenuti su più procedure analitiche 510
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 400
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? 328
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 264
What information on measurement uncertainty should be communicated to clinicians, and how? 257
Harmonization of pre-analytical quality indicators. 241
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy 241
Quality indicators to detect pre-analytical errors in laboratory testing 240
Performance criteria and quality indicators for the pre-analytical phase. 228
A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: Preliminary findings in China 225
Decision Support and Patient Safety 217
Extra-analytical sources of uncertainty: which ones really matter? 216
Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements 213
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 213
External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine 209
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 207
An integrated system for monitoring the quality of sample transportation. 206
Assessment of package inserts for diagnostic kits. 206
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 205
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 204
An Italian External Quality Assessment (EQA) program on urinary sediment. 201
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers 200
High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay 198
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 197
Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. 192
External quality assessment for biochemical markers of myocardial damage: an Italian experience. 187
A rapid, specific enzyme immunoassay for follitropin and lutropin determination. 187
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness 185
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: A consensus statement on behalf of the IFCC Working Group "laboratory Error and Patient Safety" and EFLM Task and Finish Group "performance specifications for the extra-analytical phases" 184
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 181
Reference intervals: Are interlaboratory differences appropriate? 176
External quality assessment programs in the context of ISO 15189 accreditation 175
Once upon a time: A tale of ISO 15189 accreditation 174
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Società Italiana di Biochimica Clinica), and SIPMeL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) 174
Performance specifications of critical results management 173
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 173
Evaluation of an ELISA for SARS-CoV-2 antibody testing: Clinical performances and correlation with plaque reduction neutralization titer 173
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 167
Quality indicators for laboratory diagnostics: consensus is needed. 166
Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs 166
Measurement uncertainty: Light in the shadows 166
Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches 165
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy 164
External Quality Assessment Schemes: need for recognised requirements 164
Preanalytical challenges - time for solutions 163
Risk management in laboratory medicine: quality assurance programs and professional competence. 162
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. 160
Effects of sample transportation on commonly requested laboratory tests. 160
The use of extra-analytical phase quality indicators by clinical laboratories: The results of an international survey 158
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 156
Reply to W.G. Wood. Questionable results - who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 155
Harmonization of units and reference intervals of plasma proteins: State of the art from an External Quality Assessment Scheme 155
The silk road to total quality in Laboratory Medicine 155
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 154
Importance of control materials in quality assessment of cyclosporine determination. 153
Extra-analytical quality indicators and laboratory performances 151
Quality specifications in EQA schemes: from theory to practice 150
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice 148
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 147
Extra-analytical quality indicators - Where to now? 145
Serum bone alkaline phosphatase in the follow-up of skeletal metastases. 144
Serological diagnostic for SARS-CoV-2: An experimental External Quality Assessment Scheme 143
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 141
Post-standardization of routine creatinine assays: are they suitable for clinical applications 139
Critical laboratory results: communication is just one of the problems. 137
Quality Indicators for the Total Testing Process 133
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 113
IFCC project “Model of quality indicators”: a method for results evaluation 112
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 110
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 109
The standardization of plasma protein checked by an external quality assessment scheme (EQAS) 106
Innovative software for recording preanalytical errors in accord with the IFCC quality indicators 104
Totale 14.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.628
article - articoli 36.499
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.127
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022909 0 0 158 67 23 85 59 109 45 40 110 213
2022/2023693 149 49 31 47 115 66 17 60 80 24 38 17
2023/2024474 26 41 45 45 37 30 63 22 27 17 55 66
2024/20251.639 16 106 70 79 213 34 118 113 135 68 288 399
2025/20266.355 227 564 938 1.123 569 229 631 574 619 417 254 210
2026/20271.233 323 792 118 0 0 0 0 0 0 0 0 0
Totale 14.617